Tuis539523 • BOM
add
Alkem Laboratories Ltd
Vorige sluiting
₹4 723,95
Dagwisseling
₹4 609,50 - ₹4 752,90
Jaarwisseling
₹4 409,90 - ₹6 440,00
Markkapitalisasie
553,45 mjd INR
Gemiddelde volume
3,59 k
P/V-verhouding
25,73
Dividend-opbrengs
0,91%
Primêre beurs
NSE
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(INR) | Des. 2024info | J/J-verandering |
---|---|---|
Inkomste | 33,74 mjd | 1,52% |
Bedryfskoste | 14,96 mjd | 8,29% |
Netto inkomste | 6,26 mjd | 5,19% |
Netto winsgrens | 18,55 | 3,63% |
Wins per aandeel | 52,34 | -2,59% |
EBITDA | 7,39 mjd | 4,74% |
Effektiewe belastingkoers | 12,35% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(INR) | Des. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 22,89 mjd | -36,59% |
Totale bates | — | — |
Totale aanspreeklikheid | — | — |
Totale ekwiteit | 119,10 mjd | — |
Uitstaande aandele | 119,57 m | — |
Prys om te bespreek | 4,91 | — |
Opbrengs op bates | — | — |
Opbrengs op kapitaal | 12,59% | — |
Kontantvloei
Netto kontantverandering
(INR) | Des. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | 6,26 mjd | 5,19% |
Kontant van bedrywe | — | — |
Kontant van beleggings | — | — |
Kontant van finansiering | — | — |
Netto kontantverandering | — | — |
Beskikbare kontantvloei | — | — |
Meer oor
Alkem Laboratories Limited is a leading Indian multinational pharmaceutical company headquartered in Mumbai, India. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets a diverse portfolio of pharmaceutical generics, formulations and nutraceuticals across India and global markets.
With over five decades of expertise in the pharmaceutical industry, Alkem's journey began with a vision to transform India's healthcare landscape. Today, the company has established its presence in over 40 countries, operating 19 state-of-the-art manufacturing facilities and driving innovation through a team of 500+ scientists. Backed by a robust portfolio of 800+ brands, Alkem continues to set industry benchmarks in research, development, and manufacturing excellence.
Alkem primarily focuses on developing medications for a wide range of therapeutic areas, including infectious diseases, gastrointestinal disorders, pain management, gynecological conditions, pediatrics, osteoporosis, arthritis, cardiovascular diseases, diabetes, and several other critical health concerns. Wikipedia
Gestig
1973
Hoofkwartier
Webwerf
Werknemers
17 432